A recent study suggests people may have protection from the coronavirus for years if they received the Pfizer-BioNTech or Moderna vaccine. The study was published in the journal Nature. “Overall, our ...
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
A new study shows the Pfizer-BioNTech vaccine remains 90% effective at preventing COVID-19 hospitalizations for up to six months after being fully vaccinated, even with the more transmissible delta ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (WTVO) – A new study suggests the Pfizer and ...
Please provide your email address to receive an email when new articles are posted on . RSVpreF had a vaccine effectiveness of 92% for patients aged 60 years or older. Effectiveness remained at 90% or ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
A look at how the Pfizer vaccine is performing in the real-world suggests it may not be as effective against the coronavirus variant that was first discovered in South Africa. A recently released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results